Delivery Order SPE2DB20D7059-SPE2DB25FQAP1

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,426.36 firm fixed-price delivery order is for the supply of 4567027950 - TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award SPE2DB24D1205|SPE2DB25FCTBR was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,741.12 firm fixed price delivery order contract is for the supply of 4566942403 ! TELMISARTAN 40 MG TABLET 30S, with a completion date of January 16, 2025. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,669.19 firm fixed-price delivery order is for the supply of 4564847169 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,931.00 firm fixed-price delivery order is for the supply of 4565025009 - TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, with a performance period through July 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FAPR2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order valued at $1,669.66 with a firm fixed price. It covers the procurement of 4567408393 - TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. Amerisourcebergen holds a significant Indefinite...
This federal contract award, with ID SPE2DX15D1205|SPE2DX23F71Y4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,532.45 firm fixed-price delivery order is for the supply of 4562235736 TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,674.67, is a delivery order for the supply of 4565040739 - TELMISARTAN 40 MG TABLET 30S. The contract has an ultimate completion date of July 2, 2024 and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,004.26 firm-fixed-price delivery order is for the supply of 4563134465 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of December 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, with identification number SPE2DB20D1100|SPE2DB24FA0Z5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,373.02, is for the delivery of 4563573438 ! TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. This is a firm fixed-price delivery order contract with a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.82 firm fixed-price delivery order is for the supply of 4566680655 - TELMISARTAN 80 MG TABLET 30S, with a performance period ending on December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQAP1
    Delivery Order

This federal contract award SPE2DB20D7059|SPE2DB25FQAP1 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,606.90 Firm Fixed Price delivery order is for the supply of 4567351683 ! TELMISARTAN 40 MG TABLET 30S, with a period of performance through February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated as a set-aside.

Generated 6/1/25, 2:53 AM